The next-generation Closed-System Drug-Transfer Device (CSTD) from BD that advances hazardous drug protection
Safety. Performance. Ergonomics. Ease of use. We've optimized every component, and the result is a CSTD with design innovations that advance hazardous drug safety. The BD PhaSeal™ Optima system meets the requirements of the NIOSH IPA draft CSTD-test protocol‡, a robust test protocol applicable to barrier-type closed system drug transfer devices.1,2
Airtight
Every component is designed with no inlets or air exchange for completely airtight hazardous drug transfers.
Demonstrated
The BD PhaSeal™ Optima system prevents microbial ingress for up to 168 hours and 10 penetrations*†
Efficient
The BD PhaSeal™ Optima system minimizes residual drug loss in vials compared to other similar system.
User-validated
Feedback from longstanding CSTD users and traditional technique users guided us to optimize and innovate the design.
Safety
Performance
Ergonomics
Ease of use
This is a modal window.
Beginning of dialog window. Escape will cancel and close the window.
End of dialog window.
This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.
This is a modal window.
Beginning of dialog window. Escape will cancel and close the window.
End of dialog window.
This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.
Protect clinicians and patients from exposure to hazardous drugs with a closed system
Get results in less than 10 minutes with the first and only rapid hazardous drug* detection system
Please note, not all products, services or features of products and services may be available in your local area. Please check with your local BD representative.
Notes
‡2015
*Within an ISO Class V environment following aseptic technique.
†The ability to prevent microbial ingress for up to 168 hours should not be interpreted as modifying, extending or superseding a manufacturer's labeling recommendations for the storage and expiration dating of the drug vial. Refer to drug manufacturer’s recommendations and USP compounding guidelines for shelf life and sterility information.
References